Stochastic curtailment tests for phase II trial with time-to-event outcome using the concept of relative time in the case of non-proportional hazards
- 14 August 2023
- journal article
- research article
- Published by Taylor & Francis in Journal of Biopharmaceutical Statistics
- Vol. 34 (4) , 596-611
Abstract
As part of the drug development process, interim analysis is frequently used to design efficient phase II clinical trials. A stochastic curtailment framework is often deployed wherein a decision to continue or curtail the trial is taken at each interim look based on the likelihood of observing a positive or negative treatment effect if the trial were to continue to its anticipated end. Thus, curtailment can take place due to evidence of early efficacy or futility. Traditionally, in the case of time-to-event endpoints, interim monitoring is conducted in a two-arm clinical trial using the log-rank test, often with the assumption of proportional hazards. However, when this is violated, the log-rank test may not be appropriate, resulting in loss of power and subsequently inaccurate sample sizes. In this paper, we propose stochastic curtailment methods for two-arm phase II trial with the flexibility to allow non-proportional hazards. The proposed methods are built utilizing the concept of relative time assuming that the survival times in the two treatment arms follow two different Weibull distributions. Three methods - conditional power, predictive power and Bayesian predictive probability - are discussed along with corresponding sample size calculations. The monitoring strategy is discussed with a real-life example.Keywords
Funding Information
- No funding
This publication has 42 references indexed in Scilit:
- Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcomeBMC Medical Research Methodology, 2013
- Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefitTrials, 2011
- A systematic review of the reporting of Data Monitoring Committees' roles, interim analysis and early termination in pediatric clinical trialsBMC Pediatrics, 2009
- A Conditional Power Approach to the Evaluation of Predictive PowerStatistics in Biopharmaceutical Research, 2009
- The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of biasBMC Medical Research Methodology, 2008
- A review of methods for futility stopping based on conditional powerStatistics in Medicine, 2005
- Bayesian predictive approach to interim monitoring in clinical trialsStatistics in Medicine, 2005
- Monitoring: Bayesian Data Monitoring in Clinical Trials2004
- Statistical Approaches to Interim Monitoring of Medical Trials: A Review and CommentaryStatistical Science, 1990
- Asymmetric group sequential boundaries for monitoring clinical trialsBiometrika, 1982